Stay updated on Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    New revision v3.5.4 appears in the Record History, replacing v3.5.3 and signaling a newer version of the record.
    Difference
    0.1%
    Check dated 2026-05-15T07:45:47.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision indicator updates from v3.5.2 to v3.5.3, reflecting a change in the site’s current software version rather than the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:12.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; Deleted revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:27.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 on the Record History page.
    Difference
    0.1%
    Check dated 2026-03-19T04:49:32.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Added revision v3.4.3 to the Record History and removed revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:34:15.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the previous notice about government funding and operating status; the page now displays Revision: v3.4.2.
    Difference
    0.9%
    Check dated 2026-02-11T11:43:12.000Z thumbnail image

Stay in the know with updates to Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.